Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
boston blog main
clinical trials
4
×
life sciences
national blog main
blueprint medicines
boston top stories
cancer
fda
national top stories
san francisco blog main
san francisco top stories
avapritinib
biotech
boston
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
andrew berens
arena pharmaceuticals
cardiovascular disease
colorectal cancer
companion diagnostic
cstone pharmaceuticals
What
cancer
4
×
drug
fda
4
×
medicine
approval
blueprint
marketing
announced
approved
candidate
chasing
currently
deadly
deciphera
deeper
dna
eisai
filing
fingerprint
flags
forms
genetic
gi
going
higher
incidence
lorcaserin
loss
market
matter
medicines
morning
muscle
nd
new
oks
pact
patients
pharamceuticals
plans
Language
unset
Current search:
photo
×
fda
×
" clinical trials "
×
cancer
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues